JNJ-63723283, JNJ-42756493, JNJ-42756493, JNJ-42756493
SOGUG2020IEC(VEJ)11
Phase 2 small_molecule active
Quick answer
JNJ-63723283, JNJ-42756493, JNJ-42756493, JNJ-42756493 for Muscle-invasive bladder cancer (MIBC) is a Phase 2 program (small_molecule) at Tour Hekla with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Tour Hekla
- Indication
- Muscle-invasive bladder cancer (MIBC)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active